QL2107

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for QL2107, covering 2025-04-27 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients [Phase 1, Phase 2]